These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24055850)

  • 1. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
    Zheng JH; Guida LA; Rower C; Castillo-Mancilla J; Meditz A; Klein B; Kerr BJ; Langness J; Bushman L; Kiser J; Anderson PL
    J Pharm Biomed Anal; 2014 Jan; 88():144-51. PubMed ID: 24055850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
    Delahunty T; Bushman L; Robbins B; Fletcher CV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1907-14. PubMed ID: 19493710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry.
    Jimmerson LC; Zheng JH; Bushman LR; MacBrayne CE; Anderson PL; Kiser JJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():18-24. PubMed ID: 24291608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.
    Zheng JH; Rower C; McAllister K; Castillo-Mancilla J; Klein B; Meditz A; Guida LA; Kiser JJ; Bushman LR; Anderson PL
    J Pharm Biomed Anal; 2016 Apr; 122():16-20. PubMed ID: 26829517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
    Castillo-Mancilla JR; Zheng JH; Rower JE; Meditz A; Gardner EM; Predhomme J; Fernandez C; Langness J; Kiser JJ; Bushman LR; Anderson PL
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):384-90. PubMed ID: 22935078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of intracellular tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots for pre-exposure prophylaxis adherence.
    Tsuchiya K; Hayashi Y; Ryu S; Tran HT; Takano M; Tanaka K; Mizushima D; Oka S; Gatanaga H; Hamada A
    J Infect Chemother; 2024 Sep; 30(9):876-880. PubMed ID: 38431219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
    Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
    Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
    J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots.
    Schauer AP; Sykes C; Cottrell ML; Prince H; Kashuba ADM
    J Pharm Biomed Anal; 2018 Feb; 149():40-45. PubMed ID: 29100029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
    D'Avolio A; Sciandra M; Siccardi M; Baietto L; Gonzalez de Requena D; Bonora S; Di Perri G
    J Chromatogr Sci; 2008 Jul; 46(6):524-8. PubMed ID: 18647474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.
    Gandhi M; Glidden DV; Liu A; Anderson PL; Horng H; Defechereux P; Guanira JV; Grinsztejn B; Chariyalertsak S; Bekker LG; Grant RM;
    J Infect Dis; 2015 Nov; 212(9):1402-6. PubMed ID: 25895984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.
    de Lastours V; Fonsart J; Burlacu R; Gourmel B; Molina JM
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4905-7. PubMed ID: 21788466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
    Bushman LR; Kiser JJ; Rower JE; Klein B; Zheng JH; Ray ML; Anderson PL
    J Pharm Biomed Anal; 2011 Sep; 56(2):390-401. PubMed ID: 21715120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence?
    Adams JL; Sykes C; Menezes P; Prince HM; Patterson KB; Fransen K; Crucitti T; De Baetselier I; Van Damme L; Kashuba AD
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):260-6. PubMed ID: 23111578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention.
    Jackson A; Moyle G; Watson V; Tjia J; Ammara A; Back D; Mohabeer M; Gazzard B; Boffito M
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):275-81. PubMed ID: 23274933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry.
    Jansen RS; Rosing H; Kromdijk W; ter Heine R; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):621-7. PubMed ID: 20122883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC/MS/MS method for the determination of tenofovir in monkey plasma.
    Guo J; Meng F; Li L; Zhong B; Zhao Y
    Biol Pharm Bull; 2011; 34(6):877-82. PubMed ID: 21628887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
    Hummert P; Parsons TL; Ensign LM; Hoang T; Marzinke MA
    J Pharm Biomed Anal; 2018 Apr; 152():248-256. PubMed ID: 29433097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
    Nirogi R; Bhyrapuneni G; Kandikere V; Mudigonda K; Komarneni P; Aleti R; Mukkanti K
    Biomed Chromatogr; 2009 Apr; 23(4):371-81. PubMed ID: 18937306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study.
    Li W; Doherty J; Moench P; Flarakos J; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():117-24. PubMed ID: 25645810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.